304 related articles for article (PubMed ID: 32764209)
1. Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease.
Park YM; Ha E; Gu KN; Shin GY; Lee CK; Kim K; Kim HJ
Clin Transl Gastroenterol; 2020 Jul; 11(7):e00213. PubMed ID: 32764209
[TBL] [Abstract][Full Text] [Related]
2. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
[TBL] [Abstract][Full Text] [Related]
3. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
4. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.
Li E; Zhang Y; Tian X; Wang X; Gathungu G; Wolber A; Shiekh SS; Sartor RB; Davidson NO; Ciorba MA; Zhu W; Nelson LM; Robertson CE; Frank DN
PLoS One; 2019; 14(2):e0213108. PubMed ID: 30818349
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
[TBL] [Abstract][Full Text] [Related]
7. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease.
Ryan FJ; Ahern AM; Fitzgerald RS; Laserna-Mendieta EJ; Power EM; Clooney AG; O'Donoghue KW; McMurdie PJ; Iwai S; Crits-Christoph A; Sheehan D; Moran C; Flemer B; Zomer AL; Fanning A; O'Callaghan J; Walton J; Temko A; Stack W; Jackson L; Joyce SA; Melgar S; DeSantis TZ; Bell JT; Shanahan F; Claesson MJ
Nat Commun; 2020 Mar; 11(1):1512. PubMed ID: 32251296
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
9. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
10. Fungal microbiota dysbiosis in IBD.
Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
[TBL] [Abstract][Full Text] [Related]
12. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
[TBL] [Abstract][Full Text] [Related]
14. A microbial signature for Crohn's disease.
Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
[TBL] [Abstract][Full Text] [Related]
15. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
19. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.
Moltzau Anderson J; Lipinski S; Sommer F; Pan WH; Boulard O; Rehman A; Falk-Paulsen M; Stengel ST; Aden K; Häsler R; Bharti R; Künzel S; Baines JF; Chamaillard M; Rosenstiel P
Cell Mol Gastroenterol Hepatol; 2020; 10(2):365-389. PubMed ID: 32289499
[TBL] [Abstract][Full Text] [Related]
20. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
